Literature DB >> 9214599

Antigenic phenotypes common to rat oval cells, primary hepatocellular carcinomas and developing bile ducts.

D C Hixson1, L Chapman, A McBride, R Faris, L Yang.   

Abstract

The shared expression of monoclonal antibody-defined antigens by oval cells and by bile ducts, neoplastic nodules and primary hepatocellular carcinomas (PHC) has provided support for the ability of oval cells to undergo differentiation along ductular or hepatocyte lineages and/or to progress to hepatocellular carcinoma. With the aim of obtaining additional insight into this process, we have combined serial section and double labeling immunofluorescence analysis to determine if phenotypes expressed in vitro by four rat oval cell lines and the H5D.61 hepatocellular carcinoma cell line and in situ by ethionine-induced primary hepatocellular carcinomas reproduce antigenic patterns occurring during normal liver development. Analysis using monoclonal antibodies specific for the oval cell antigens OV6 and OC.2 and hepatocyte markers HBD.1 and H.4 defined subpopulations in four oval cell lines and neoplastic hepatocytes in PHC and H5D.61 with OC.2-/OV6+ and OC.2+/OV6+ phenotypes. Cells with an OC2+/OV6- phenotype were rarely observed in cell lines or primary tumors. In contrast, areas composed of OV6+/H.4+ cells were frequently found in PHC. Examination of fetal and neonatal rat livers demonstrated the stage-specific appearance of three of these phenotypes during liver development. The OC.2+/OV6- phenotype appeared transiently prior to embryonic day (ED) 18 in a subpopulation of HBD.1+ hepatoblasts. OV6 expression was first detected at ED18 on developing bile ducts that were negative for OC.2. These newly formed ducts rapidly acquired OC.2, starting with ducts in the hilar region and spreading outward towards the periphery. This OC.2 expression gradient persisted in the newborn rat liver but became more skewed towards doubly positive cells, with OC.2-/OV6+ cells being found primarily in the periphery. Hepatocytes expressing both OV6 and H.4 were not observed in fetal liver but appeared in neonatal liver in close proximity to OV6+ interlobular ducts. From these findings, it was concluded that oval cells and PHC display phenotypes representing normal stages in liver development, suggesting that oval cells and cells within ethionine-induced PHC are capable of initiating but are unable to complete pathways of hepatocytic or biliary differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9214599     DOI: 10.1093/carcin/18.6.1169

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  18 in total

1.  Differential expression of the rat gamma-glutamyl transpeptidase gene promoters along with differentiation of hepatoblasts into biliary or hepatocytic lineage.

Authors:  N Holic; T Suzuki; A Corlu; D Couchie; M N Chobert; C Guguen-Guillouzo; Y Laperche
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Hepatic stem cells: from inside and outside the liver?

Authors:  M R Alison; P Vig; F Russo; B W Bigger; E Amofah; M Themis; S Forbes
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

3.  Persistent effect of mTOR inhibition on preneoplastic foci progression and gene expression in a rat model of hepatocellular carcinoma.

Authors:  Heather Francois-Vaughan; Adeola O Adebayo; Kate E Brilliant; Nicola M A Parry; Philip A Gruppuso; Jennifer A Sanders
Journal:  Carcinogenesis       Date:  2016-02-10       Impact factor: 4.944

4.  Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury.

Authors:  George K Michalopoulos; Lindsay Barua; William C Bowen
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

Review 5.  Stem cells versus plasticity in liver and pancreas regeneration.

Authors:  Janel L Kopp; Markus Grompe; Maike Sander
Journal:  Nat Cell Biol       Date:  2016-03       Impact factor: 28.824

Review 6.  Evidence regarding a stem cell origin of hepatocellular carcinoma.

Authors:  Thomas Shupe; Bryon E Petersen
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

7.  The cholangiocyte marker, BD. 1, forms a stable complex with CLIP170 and shares an identity with eIF3a, a multifunctional subunit of the eIF3 initiation complex.

Authors:  David R Mills; Rebecca A Rozich; Donna L Flanagan; Kate E Brilliant; DongQin Yang; Douglas C Hixson
Journal:  Exp Mol Pathol       Date:  2012-05-18       Impact factor: 3.362

8.  Accumulation of neoplastic traits prior to spontaneous in vitro transformation of rat cholangiocytes determines susceptibility to activated ErbB-2/Neu.

Authors:  Rebecca A Rozich; David R Mills; Kate E Brilliant; Helen M Callanan; DongQin Yang; Umadevi Tantravahi; Douglas C Hixson
Journal:  Exp Mol Pathol       Date:  2010-07-22       Impact factor: 3.362

9.  Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.

Authors:  Jing-Lin Xia; Chunsun Dai; George K Michalopoulos; Youhua Liu
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 10.  Liver regeneration: alternative epithelial pathways.

Authors:  George K Michalopoulos
Journal:  Int J Biochem Cell Biol       Date:  2009-09-27       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.